Close Menu
    National News Brief
    Sunday, November 22
    • Home
    • Business
    • Lifestyle
    • Science
    • Technology
    • International
    • Arts & Entertainment
    • Sports
    National News Brief
    Home » Erectile dysfunction drug could hold promise for Alzheimer’s disease

    Erectile dysfunction drug could hold promise for Alzheimer’s disease

    Team_NationalNewsBriefBy Team_NationalNewsBriefNovember 22, 2026 Science No Comments4 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email


    A drug developed to treat erectile dysfunction might seem an unlikely treatment for Alzheimer’s disease. But researchers are increasingly interested in whether medicines such as Viagra could also help protect the brain.

    These drugs affect blood flow and other processes that may play a role in brain health. An experimental drug called AR1001 has produced encouraging results in a large international clinical trial.

    In one group of people with early Alzheimer’s, the drug was reported to slow the worsening of symptoms by 31% over a year, compared with a placebo.


    On supporting science journalism

    If you’re enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


    AriBio, a South Korean biotechnology company, announced the results at the 19th Clinical Trials on Alzheimer’s Disease conference in Boston, US. A full scientific paper, reviewed by other researchers, has not yet been published.

    The phase three trial—the final phase of testing in humans—involved 1,535 people with early Alzheimer’s in 13 countries. Participants took either 30mg of AR1001 or a placebo every day for a year.

    Researchers measured changes in memory, thinking and everyday activities. They looked at two groups: everyone who took part in the trial and a smaller group of 604 people who were not taking other Alzheimer’s medicines to ease their symptoms, such as donepezil or memantine.

    Only this smaller group saw a 31 percent reduction in worsening symptoms. Across the whole trial, AR1001 did not produce reliable benefits.

    How could erectile dysfunction drugs affect the brain?

    Erectile dysfunction drugs work by blocking an enzyme that normally breaks down a chemical messenger – called cGMP – in the body. This allows cGMP to build up, helping the muscles around blood vessels relax. The vessels widen, allowing more blood to flow through them. This is how the drugs help treat erectile dysfunction.

    The same chemical messenger also helps brain cells communicate with each other. Researchers think that increasing its levels could help brain cells survive and maintain the connections they need to share information.

    These connections are essential for learning and memory. Alzheimer’s gradually damages them, making it harder to remember things and think clearly. Researchers hope that AR1001 might help protect some of these connections and slow the damage caused by the disease.

    However, this is still a theory. The clinical trial does not show that these biological changes explain the reported benefits in people.

    Some laboratory and animal studies support the idea. In a 2022 study, mice with features of Alzheimer’s disease performed better in memory tests after receiving AR1001. The treatment also reduced levels of amyloid-beta and abnormal tau, two proteins linked to Alzheimer’s.

    Other experimental researchin mice has found that AR1001 can increase levels of cGMP and a protein that helps brain cells survive. However, results in animals do not always translate into benefits for humans.

    Interest in this family of drugs has also grown following research in people. A 2024 studyfollowed more than 269,000 men with erectile dysfunction. It found that men prescribed these drugs were 18% less likely to be diagnosed with Alzheimer’s than men who were not prescribed them.

    But this was an observational study, which means it cannot show that the drugs themselves reduced the risk of Alzheimer’s. The two groups may have differed in other ways that influenced the results.

    A complicated relationship

    The relationship between erectile dysfunction and Alzheimer’s is complicated. Erectile dysfunction can be associated with conditions such as diabetes, high blood pressure and heart disease, which can damage blood vessels. These same conditions are also linked to poorer brain health and a higher risk of dementia.

    This means that some of the apparent link between erectile dysfunction, its treatments and dementia could be down to shared risk factors affecting blood vessels, rather than a direct effect of the drugs.

    Erectile dysfunction drugs are not an established treatment for Alzheimer’s, and nothing in these results suggests people should take them to protect their memory.

    The latest trial does, however, keep alive an interesting possibility: that drugs that improve blood flow and help brain cells communicate might also slow the damage caused by Alzheimer’s.

    Whether this is the case will depend on the full trial results and further research in people, including studies looking at why the apparent benefit was seen only among those not taking other Alzheimer’s medicines.

    This article was first published by The Conversation. Read the original article here.



    Source link

    Team_NationalNewsBrief
    • Website

    Keep Reading

    Two probes are about to arrive at Mercury for an up-close look at this puzzling planet

    Anthropic mathematician proves Riemann hypothesis, most famous problem in all of math

    What the Riemann hypothesis proof really means about AI and the future

    What do other planets smell like? The answer hides in their chemistry

    Weirdly accelerating space rock keeps puzzling astronomers

    Math Puzzle: The longest shuffle

    Add A Comment

    Comments are closed.

    Editors Picks

    How RFK Jr. helped drive America to this moment

    March 1, 2025

    Fed minutes show deep division at the December meeting

    December 31, 2025

    How far-right leader Marine Le Pen is using protests against Emmanuel Macron

    October 20, 2026

    Ash trees are rapidly evolving some resistance to ash dieback disease

    June 27, 2025

    California Bans Most Law Enforcement, Including Federal Agents, From Wearing Masks

    September 23, 2025
    Categories
    • Arts & Entertainment
    • Business
    • International
    • Latest News
    • Lifestyle
    • Opinions
    • Politics
    • Science
    • Sports
    • Technology
    • Top Stories
    • Trending News
    • World Economy
    About us

    Welcome to National News Brief, your one-stop destination for staying informed on the latest developments from around the globe. Our mission is to provide readers with up-to-the-minute coverage across a wide range of topics, ensuring you never miss out on the stories that matter most.

    At National News Brief, we cover World News, delivering accurate and insightful reports on global events and issues shaping the future. Our Tech News section keeps you informed about cutting-edge technologies, trends in AI, and innovations transforming industries. Stay ahead of the curve with updates on the World Economy, including financial markets, economic policies, and international trade.

    Editors Picks

    Your Business Is Busy. But Is It Actually Growing?

    November 22, 2026

    Erectile dysfunction drug could hold promise for Alzheimer’s disease

    November 22, 2026

    California prepares for flooding, rain and wind as Thanksgiving approaches

    November 22, 2026

    The AI Superintelligence Debate Has Serious Flaws

    November 22, 2026
    Categories
    • Arts & Entertainment
    • Business
    • International
    • Latest News
    • Lifestyle
    • Opinions
    • Politics
    • Science
    • Sports
    • Technology
    • Top Stories
    • Trending News
    • World Economy
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About us
    • Contact us
    Copyright © 2024 Nationalnewsbrief.com All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.